<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sarkar S</submitter><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>2165-2178</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9526446</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(8)</volume><pubmed_abstract>The methylation of peptide backbone amides is a hallmark of bioactive natural products, and it also greatly modifies the pharmacology of synthetic peptides. Usually, bioactive &lt;i>N&lt;/i>-methylated peptides are cyclic. However, there is very limited knowledge about how post-translational enzymes can be applied to the synthesis of designed &lt;i>N&lt;/i>-methylated peptides or peptide libraries. Here, driven by the established ability of some RiPP enzymes to process diverse substrates, we sought to define catalysts for the &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i> macrocyclization of backbone-methylated peptides. We developed efficient methods in which short, synthetic &lt;i>N&lt;/i>-methylated peptides could be modified using side chain and mainchain macrocyclases, PsnB and PCY1 from plesiocin and orbitide bio</pubmed_abstract><journal>ACS chemical biology</journal><pubmed_title>Applying Promiscuous RiPP Enzymes to Peptide Backbone &lt;i>N&lt;/i>-Methylation Chemistry.</pubmed_title><pmcid>PMC9526446</pmcid><funding_grant_id>R35 GM122521</funding_grant_id><funding_grant_id>R35GM122521</funding_grant_id><pubmed_authors>Sarkar S</pubmed_authors><pubmed_authors>Schmidt EW</pubmed_authors><pubmed_authors>Gu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Applying Promiscuous RiPP Enzymes to Peptide Backbone &lt;i>N&lt;/i>-Methylation Chemistry.</name><description>The methylation of peptide backbone amides is a hallmark of bioactive natural products, and it also greatly modifies the pharmacology of synthetic peptides. Usually, bioactive &lt;i>N&lt;/i>-methylated peptides are cyclic. However, there is very limited knowledge about how post-translational enzymes can be applied to the synthesis of designed &lt;i>N&lt;/i>-methylated peptides or peptide libraries. Here, driven by the established ability of some RiPP enzymes to process diverse substrates, we sought to define catalysts for the &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i> macrocyclization of backbone-methylated peptides. We developed efficient methods in which short, synthetic &lt;i>N&lt;/i>-methylated peptides could be modified using side chain and mainchain macrocyclases, PsnB and PCY1 from plesiocin and orbitide bio</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T20:06:54.8Z</modification><creation>2025-04-04T20:06:54.8Z</creation></dates><accession>S-EPMC9526446</accession><cross_references><pubmed>35819062</pubmed><doi>10.1021/acschembio.2c00293</doi></cross_references></HashMap>